ADDLIFE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.4 SEK | +1.80% |
|
+7.40% | -1.83% |
| May. 08 | AddLife AB Approves Dividend, Payable on 16 May 2024 | CI |
| Apr. 24 | Transcript : AddLife AB, Q1 2024 Earnings Call, Apr 24, 2024 |
Presenter SpeechKristina Willgård (Executives)Hi, everybody, and most welcome to this short pr...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Calendar
2024-07-15
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
107.4
SEK
Average target price
137
SEK
Spread / Average Target
+27.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.83% | 1.2B | |
| +23.37% | 47.02B | |
| +48.83% | 41.86B | |
| -0.94% | 41.76B | |
| -5.86% | 28.8B | |
| +11.29% | 26.05B | |
| -20.92% | 19.15B | |
| +3.20% | 12.55B | |
| -2.67% | 11.82B | |
| +30.23% | 12.34B |
- Stock Market
- Equities
- ALIF B Stock
- News AddLife AB
- Transcript : AddLife AB, Healthcare 21 Ltd - M&A Call